Elexacaftor-Tezacaftor-Ivacaftor improves exercise capacity in adolescents with cystic fibrosis. Causer AJ, Shute JK, Cummings MH, Shepherd AI, et al. Pediatr Pulmonol 2022;57:2652-2658.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Causer AJ, Shute JK, Cummings MH, Shepherd AI, et al. Elexacaftor-Tezacaftor-Ivacaftor improves exercise capacity in adolescents with cystic fibrosis. Pediatr Pulmonol 2022;57:2652-2658.
PMID: 35851858